ARxIUM announces that its RIVA automated IV compounding systems have accurately and safely prepared more than 10 million IV doses in acute care hospitals, centralized pharmacies, and cancer centers. The system can be configured for use in general/adult areas, chemotherapy, pediatric, health system centralized services, and 503B facilities. The GMP RIVA provides integrated system controls with audible and visual alerts and extensive reporting capabilities. The system also contains new features to meet cGMP regulations for environmental monitoring.

ARxIUM